Depressive Disorder: all 4,846 studies

Page 8 of 49. Open to participants first (508), then studies with results posted, then the rest; newest registration first within each.

• Anxiety and Depression in Epilepsy: A Treatment StudyCompletedNCT03464383Phase 4Results posted
• A Clinical Trial of Oral Ganaxolone in Women With Postpartum DepressionCompletedNCT03460756Phase 2Results posted
• Single Session of tACS in a Depressive EpisodeCompletedNCT03449979Not applicableResults posted
• A Study to Evaluate the Efficacy and Safety of MIN-117 in Adult Patients With Major Depressive DisorderCompletedNCT03446846Phase 2Results posted
• A Study to Evaluate the Efficacy, Pharmacokinetics, Safety and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant DepressionCompletedNCT03434041Phase 3Results posted
• Spinal Cord Stimulation for the Treatment of Major Depressive DisorderCompletedNCT03433339Phase 1/2Results posted
• Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative MechanismsCompletedNCT03429075Phase 2Results posted
• Brexpiprazole for Bipolar DepressionCompletedNCT03427892Phase 4Results posted
• Development, Feasibility and Acceptability of Fathers and Babies (FAB): A Pilot StudyCompletedNCT03427528Not applicableResults posted
• Healthy Lifestyle Intervention for High-Risk Minority Pregnant WomenCompletedNCT03416010Not applicableResults posted
• A Study of Duloxetine (LY248686) in the Treatment of Japanese Children and Adolescents With Depressive DisorderTerminatedNCT03395353Phase 3Results posted
• Identifying and Treating Depression in Hemodialysis PatientsCompletedNCT03390933Phase 4Results posted
• Adherence to Antidepressant Treatment in Subjects With DepressionTerminatedNCT03388164Phase 2Results posted
• The Safety and Efficacy of Naltrexone and Scopolamine Utilized in the Treatment of Major DepressionCompletedNCT03386448Phase 4Results posted
• Efficacy of Resveratrol in DepressionCompletedNCT03384329Phase 4Results posted
• Metformin, Vitamin D, and Depression in Polycystic Ovary Syndrome (PCOS) TrialTerminatedNCT03380091Phase 4Results posted
• rTMS for MDD: 5.5cm Rule vs. F3 TargetingCompletedNCT03378570Not applicableResults posted
• Program ACTIVE II: Behavioral Depression Treatment for Type 2 DiabetesCompletedNCT03371940Not applicableResults posted
• Biomarkers in Repetitive Transcranial Magnetic Stimulation (rTMS) for Adolescent DepressionCompletedNCT03363919Not applicableResults posted
• Long Term Follow-up of Deep Brain Stimulation for Treatment-Resistant DepressionTerminatedNCT03360942Not applicableResults posted
• A Study of Rapastinel for Rapid Treatment of Depression and Suicidality in Major Depressive DisorderTerminatedNCT03352453Phase 2Results posted
• A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant TherapyCompletedNCT03321526Phase 2Results posted
• Treating Hearing Loss to Improve Mood and Cognition in Older AdultsCompletedNCT03321006Phase 4Results posted
• A Study of Duloxetine (LY248686) in Japanese Children and Adolescents With Depressive DisorderCompletedNCT03315793Phase 3Results posted
• Intermittent Theta Burst for the Treatment of Alcohol Use Disorders in VeteransTerminatedNCT03291431Not applicableResults posted
• Adaptive Design Study of NEST sTMS in Subjects With Major Depressive DisorderCompletedNCT03288714Not applicableResults posted
• Developing E-health Services (DES): The Feasibility and Acceptability of Video-conferencing for Adults With DepressionCompletedNCT03288506Not applicableResults posted
• Inhaled Nitrous Oxide for Treatment-Resistant Depression: Optimizing Dosing StrategiesCompletedNCT03283670Phase 2Results posted
• The Safety and Efficacy of Nexalin Trans-cranial Electrical Stimulation Stimulation for the Treatment of DepressionCompletedNCT03277846Not applicableResults posted
• Transcranial Magnetic Stimulation (TMS) for Motor Symptoms in Psychiatric DisordersCompletedNCT03275766Not applicableResults posted
• A Behavioral Intervention for Depression and Chronic Pain in Primary CareCompletedNCT03265210Not applicableResults posted
• Ketamine as an Adjunctive Therapy for Major DepressionCompletedNCT03256162Phase 1Results posted
• Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted GloballyCompletedNCT03249376Phase 3Results posted
• Reaching and Engaging Depressed Senior Center Clients (REDS)CompletedNCT03246789Not applicableResults posted
• EM/PROTECT: Improving Depression in Elder Mistreatment VictimsCompletedNCT03241225Not applicableResults posted
• Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression: OL CohortCompletedNCT03240692Not applicableResults posted
• Intravenous Ketamine Plus Neurocognitive Training for DepressionCompletedNCT03237286Phase 1/2Results posted
• Our Family Our Future: A Resilience-oriented Family Intervention to Prevent Adolescent HIV/STI Infection and Depression in South AfricaCompletedNCT03231358Phase 3Results posted
• A Clinical Trial of Intravenous (IV) Ganaxolone in Women With Postpartum DepressionCompletedNCT03228394Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of JNJ-42847922 as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant TherapyCompletedNCT03227224Phase 2Results posted
• An Adaptive Algorithm-Based Approach to Treatment for Adolescent DepressionCompletedNCT03222570Phase 2Results posted
• Improving Outcomes for Low-Income Mothers With DepressionCompletedNCT03221556Not applicableResults posted
• Melancholic Depression and Insomnia as Predictors of Response to Quetiapine in Patients With Major DepressionCompletedNCT03207438Phase 4Results posted
• BTRX-246040 Administered Once Daily to Patients With Major Depressive DisorderCompletedNCT03193398Phase 2Results posted
• Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for DepressionCompletedNCT03191058Not applicableResults posted
• A Study of ALKS 5461 for Treatment Refractory Major Depressive Disorder (MDD)CompletedNCT03188185Phase 3Results posted
• Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Pediatric Participants Assessed to be at Imminent Risk for SuicideCompletedNCT03185819Phase 2Results posted
• Effects of Psilocybin in Major Depressive DisorderCompletedNCT03181529Phase 2Results posted
• The BIO-K Study: A Single-Arm, Open-Label, Biomarker Development Clinical Trial of Ketamine for Non-Psychotic Unipolar Major Depression and Bipolar I or II Depression.CompletedNCT03156504Phase 4Results posted
• Salicylic Augmentation in DepressionTerminatedNCT03152409Phase 2Results posted
• OSA Screen Negative With Spinal DuramorphTerminatedNCT03151226Not applicableResults posted
• A Study of Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD)CompletedNCT03149991Phase 4Results posted
• Neural Mechanisms of Monoaminergic Engagement in Late-life Depression Treatment Response (NEMO)CompletedNCT03128021Phase 4Results posted
• Accelerated TMS to a Novel Brain Target in MDD and PTSDCompletedNCT03114891Not applicableResults posted
• ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD)CompletedNCT03113968Phase 2/3Results posted
• Low Frequency TMS for Depression in EpilepsyCompletedNCT03105700Not applicableResults posted
• Ketamine and Nitroprusside for DepressionCompletedNCT03102736Phase 2Results posted
• 54135419SUI3002: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for SuicideCompletedNCT03097133Phase 3Results posted
• Novel Neural Circuit Biomarkers of Major Depression Response to CCBTCompletedNCT03096886Not applicableResults posted
• A Study to Evaluate the Safety and Efficacy of TS-121 as an Adjunctive Treatment for Major Depressive DisorderTerminatedNCT03093025Phase 2Results posted
• Rapid Antidepressant Effects of LeucineTerminatedNCT03079297Phase 2Results posted
• Support for Perinatal Adherence and DepressionCompletedNCT03069417Not applicableResults posted
• Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression (SAINT-TRD)CompletedNCT03068715Not applicableResults posted
• Cognitive and Mood Assessment Data in Major Depressive Disorder Using Digital Wearable TechnologyCompletedNCT03067506Results posted
• Effectiveness of a Mobile Texting Intervention for People With Serious Mental IllnessCompletedNCT03062267Not applicableResults posted
• THINC-it Vortioxetine - Sensitivity to ChangeCompletedNCT03053362Phase 2/3Results posted
• Safety, Tolerability, PK Profile, and Symptom Response of a 7-Day Dosing With 25 mg or 50 mg Daily of REL-1017 in MDDCompletedNCT03051256Phase 2Results posted
• Virtual Reality Job Interview Training in Severe Mental IllnessCompletedNCT03049813Not applicableResults posted
• Study to Treat Major Depressive Disorder With a New MedicationCompletedNCT03043560Phase 2Results posted
• 54135419SUI3001: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for SuicideCompletedNCT03039192Phase 3Results posted
• CSE v. Epidural for Postpartum DepressionCompletedNCT03022526Not applicableResults posted
• Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder (CLARITY)CompletedNCT03018340Phase 2Results posted
• Dynamics of Inflammation and Its Blockade on Motivational Circuitry in DepressionCompletedNCT03006393Phase 4Results posted
• Inflammation-Induced CNS Glutamate Changes in DepressionTerminatedNCT03004443Phase 4Results posted
• Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive DisorderCompletedNCT03002077Phase 3Results posted
• A Study to Evaluate SAGE-217 in Participants With Moderate to Severe Major Depressive DisorderCompletedNCT03000530Phase 2Results posted
• ECT Pulse Amplitude and Medial Temporal Lobe EngagementCompletedNCT02999269Phase 4Results posted
• Stepped Care for Depression in Heart FailureCompletedNCT02997865Not applicableResults posted
• Melancholic Symptoms in Bipolar Depression and Responsiveness to LamotrigineCompletedNCT02989727Phase 4Results posted
• A Study to Evaluate the Effectiveness of Juvéderm® VOLIFT®™ With Lidocaine for Dynamic Radial Cheek Line Skin DepressionsCompletedNCT02980783Phase 4Results posted
• Comparing the Effectiveness of Clinicians and Paraprofessionals to Reduce Disparities in Perinatal DepressionCompletedNCT02979444Not applicableResults posted
• A Study to Evaluate SAGE-217 in Participants With Severe Postpartum DepressionCompletedNCT02978326Phase 3Results posted
• Neuroimaging in Patients Undergoing TMS for DepressionCompletedNCT02974296Not applicableResults posted
• Sequential Therapy for the Treatment of Severe Bipolar Depression.CompletedNCT02974010Phase 2Results posted
• Goal Achievement After a Change to Vortioxetine in Adults With Major Depressive DisorderCompletedNCT02972632Phase 4Results posted
• Pattern Separation, Brain Derived Neurotrophic Factors, and Mechanisms of VortioxetineTerminatedNCT02969876Phase 4Results posted
• Optimizing Outcomes of Treatment-Resistant Depression in Older AdultsCompletedNCT02960763Phase 4Results posted
• Transcranial Laser Therapy, Continuous and Pulsed Light, for Major Depressive Disorder (ELATED-3)CompletedNCT02959307Not applicableResults posted
• A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive DisorderCompletedNCT02951988Phase 3Results posted
• A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)CompletedNCT02943564Phase 3Results posted
• Flavanol Augmentation for Antidepressant Non-Responsive Late Life DepressionTerminatedNCT02943096Not applicableResults posted
• TMS for Adults With Autism and DepressionCompletedNCT02939560Not applicableResults posted
• IMPAACT 2002: Cognitive Behavioral Therapy and Medication Management for Treatment of Depression in US Youth With HIVCompletedNCT02939131Not applicableResults posted
• Low Dose Intravenous Ketamine in Treatment Resistant Depression PatientsCompletedNCT02935595Phase 2Results posted
• A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)CompletedNCT02932943Phase 3Results posted
• Placebo-controlled Trial of 5-hydroxytryptophan and Creatine for SSRI or SNRI Augmentation in Treatment Resistant Depression in FemalesTerminatedNCT02922725Phase 4Results posted
• A Study to Evaluate the Efficacy, Safety and Tolerability of Fixed Doses of Intranasal Esketamine in Japanese Participants With Treatment Resistant DepressionCompletedNCT02918318Phase 2Results posted
• The Therapeutic Effect of Transcranial Direct Current Stimulation on Depression in Parkinson's DiseaseTerminatedNCT02917122Phase 1/2Results posted
• Antidepressant Effects of Ayahuasca: a Randomized Placebo Controlled Trial in Treatment Resistant DepressionCompletedNCT02914769Phase 1/2Results posted
• Cost- Effectiveness and Quality of Life Assessment in Major Depression DisorderCompletedNCT02901249Phase 4Results posted

← Depressive Disorder overview